Trillium Therapeutics Inc (TRIL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2011 | 06-2011 | 03-2011 | 12-2010 | 09-2010 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 57 | 64 | 65 | 68 | 67 |
| Accounts receivable | -8 | 1 | 7 | -38 | 8 |
| Other Working Capital | 142 | -168 | -14 | 111 | -444 |
| Other Operating Activity | -427 | -537 | -448 | -844 | -648 |
| Operating Cash Flow | $-236 | $-640 | $-390 | $-704 | $-1,017 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | 0 | 2 | 14 | -3 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -13 | 0 |
| Other Investing Activity | 0 | 0 | 0 | 64 | 0 |
| Investing Cash Flow | $0 | $0 | $2 | $65 | $-3 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 1,795 | 1,825 | 9 |
| Other Financing Activity | -180 | 0 | 0 | -62 | 1 |
| Financing Cash Flow | $-180 | $0 | $1,795 | $1,763 | $10 |
| Exchange Rate Effect | N/A | 0 | 65 | -19 | 19 |
| Beginning Cash Position | 3,819 | 4,458 | 2,970 | 1,643 | 2,542 |
| End Cash Position | 3,138 | 3,819 | 4,443 | 2,887 | 1,643 |
| Net Cash Flow | $-417 | $-639 | $1,407 | $1,124 | $-1,010 |
| Free Cash Flow | |||||
| Operating Cash Flow | -236 | -640 | -390 | -704 | -1,017 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -3 |
| Free Cash Flow | -236 | -640 | -390 | -704 | -1,020 |